Postech Academy-Industry Foundation

Ulsan National Institute of Science and Technology

Inje University Industry-Academic Cooperation Foundation

Unist, Inc.

Yu Jin Lee

Sung Ho Ryu

Pann-Ghill Suh

Jong Hun Im

Young Chan Chae

Jae Ha Lee

Il Hwan Kim

Ii Shin Kim

Youn Dong Kim

Myeong Ju Kang

Bong Su Park

Si Hyung Park

Kang Min Park

Seong Cheol Kim

Jae Seung Jung

Jin Han Park

So Yeong Jung

The present disclosure relates to a peritoneal cavity-bladder connecting catheter for ascites drainage. The peritoneal cavity-bladder connecting catheter for ascites drainage includes a peritoneal cavity position part positioned on the side of a peritoneal cavity by passing through a bladder wall located between the peritoneal cavity and a bladder, the peritoneal cavity position part having inlets through which ascites flow into an inner space and being formed as a film that surrounds the inner space, and a bladder position part integrally formed with the peritoneal cavity position part and positioned on the side of the bladder located on the side of the bladder wall opposite to the peritoneal cavity, the bladder position part having outlets through ascites flowed into the peritoneal cavity position part are discharged to outside, and being configured to form a closed inner space together with the peritoneal cavity position part.

Peritoneal cavity-bladder connecting catheter for ascites drainage

This disclosure relates to DNA aptamer specifically binding to periostin, which is cancer-related protein, a composition for inhibiting cancer and/or cancer metastasis and/or a composition for diagnosis of cancer and/or cancer metastasis, comprising the same as an active ingredient, wherein the aptamer has different binding mechanism from the existing antibodies, and thus, may inhibit and diagnose cancer/cancer metastasis more effectively.

Aptamer for periostin and anti-cancer composition including same

Growing community of inventors

Busan, South Korea

Yu Jin Lee